| Authors: |
King MT; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: martin_king@dfci.harvard.edu., Keyes M; Department of Radiation Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada., Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Crook JM; Department of Radiation Oncology, British Columbia Cancer Agency, University of British Columbia, Kelowna, Canada., Butler WM; Department of Radiation Oncology, Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, WV., Rossi PJ; Calaway Young Cancer Center, Valley View Hospital, Glenwood Springs, CO., Cox BW; Department of Radiation Oncology, Rush University Medical Center, Chicago, IL., Showalter TN; Department of Radiation Oncology, University of Virginia, Charlottesville, VA., Mourtada F; Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, DE., Potters L; Department of Radiation Oncology, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY., Stock RG; Department of Radiation Oncology, Mt. Sinai Medical Center, New York, NY., Kollmeier MA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Zelefsky MJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Davis BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN., Merrick GS; Department of Radiation Oncology, Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, WV., Orio PF; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA. |